A comparative analysis of the long-term efficacy between partial hepatectomy and transcatheter arterial chemoembolization in patients with liver metastasis from nasopharyngeal carcinoma

Yilin WANG; Lu WANG

doi:10.19401/j.cnki.1007-3639.2025.05.009

您当前的位置：

首页 >

文章列表页 >

A comparative analysis of the long-term efficacy between partial hepatectomy and transcatheter arterial chemoembolization in patients with liver metastasis from nasopharyngeal carcinoma

Original article | 更新时间：2025-12-31

- A comparative analysis of the long-term efficacy between partial hepatectomy and transcatheter arterial chemoembolization in patients with liver metastasis from nasopharyngeal carcinoma
- China Oncology Vol. 35, Issue 5, Pages: 505-509(2025)
- 作者机构：
  
  复旦大学附属肿瘤医院肝脏外科，复旦大学上海医学院肿瘤学系，上海 200032
- 作者简介：
- 基金信息：
  
  Shanghai Shenkang “Three-Year Action Plan for Promoting Clinical Skills and Clinical Innovation in Municipal Hospitals” Project(SHDC2024CRI094)
- DOI：10.19401/j.cnki.1007-3639.2025.05.009
  CLC： R735.7
- Received：21 October 2024，
  
  Revised：2025-03-23，
  
  Published：30 May 2025
- 稿件说明：
移动端阅览
Yilin WANG, Lu WANG. A comparative analysis of the long-term efficacy between partial hepatectomy and transcatheter arterial chemoembolization in patients with liver metastasis from nasopharyngeal carcinoma[J]. China Oncology, 2025, 35(5): 505-509.
DOI：

Yilin WANG, Lu WANG. A comparative analysis of the long-term efficacy between partial hepatectomy and transcatheter arterial chemoembolization in patients with liver metastasis from nasopharyngeal carcinoma[J]. China Oncology, 2025, 35(5): 505-509. DOI： 10.19401/j.cnki.1007-3639.2025.05.009.

摘要

Abstract

关键词

Keywords

references

BRAY F , LAVERSANNE M , SUNG H , et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2024 , 74 ( 3 ): 229 - 263 .

WEI W I , SHAM J S . Nasopharyngeal carcinoma [J ] . Lancet , 2005 , 365 ( 9476 ): 2041 - 2054 . DOI: 10.1016/S0140-6736(05)66698-6 http://doi.org/10.1016/S0140-6736(05)66698-6

JIN Y , CAI X Y , CAI Y C , et al. To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic area [J ] . Eur J Cancer , 2012 , 48 ( 6 ): 882 - 888 . DOI: 10.1016/j.ejca.2011.09.004 http://doi.org/10.1016/j.ejca.2011.09.004

LIU G Y , YE Y F , JIANG Y F , et al. Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial [J ] . BMJ , 2024 , 385 : e077890 .

LI W Z , HUA X , LV S H , et al. A scoring system based on nutritional and inflammatory parameters to predict the efficacy of first-line chemotherapy and survival outcomes for de novo metastatic nasopharyngeal carcinoma [J ] . J Inflamm Res , 2021 , 14 : 817 - 828 .

HUANG J , LI Q J , ZHENG Y , et al. Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature [J ] . BMC Cancer , 2014 , 14 : 818 . DOI: 10.1186/1471-2407-14-818 http://doi.org/10.1186/1471-2407-14-818

FENG Y , ZHAO Y M , LI W W , et al. Hepatic resection prolongs overall survival in the selected patients with nasopharyngeal carcinoma liver metastases [J ] . Eur J Surg Oncol , 2022 , 48 ( 10 ): 2202 - 2211 . DOI: 10.1016/j.ejso.2022.05.033 http://doi.org/10.1016/j.ejso.2022.05.033

ELIAS D , CAVALCANTI DE ALBUQUERQUE A , EGGENSPIELER P , et al. Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients [J ] . J Am Coll Surg , 1998 , 187 ( 5 ): 487 - 493 .

WEITZ J , BLUMGART L H , FONG Y , et al. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma [J ] . Ann Surg , 2005 , 241 ( 2 ): 269 - 276 . DOI: 10.1097/01.sla.0000150244.72285.ad http://doi.org/10.1097/01.sla.0000150244.72285.ad

POL B , CAMPAN P , HARDWIGSEN J , et al. Morbidity of major hepatic resections: a 100-case prospective study [J ] . Eur J Surg , 1999 , 165 ( 5 ): 446 - 453 . DOI: 10.1080/110241599750006686 http://doi.org/10.1080/110241599750006686

COUINAUD C . Anatomic principles of left and right regulated hepatectomy: technics [J ] . J Chir (Paris) , 1954 , 70 ( 12 ): 933 - 966 .

KAWASAKI S , SUGIYAMA Y , IGA T , et al. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients [J ] . Am J Gastroenterol , 1985 , 80 ( 10 ): 801 - 806 .

CHUA D T T , SHAM J S T , AU G K H . A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy [J ] . Oral Oncol , 2003 , 39 ( 4 ): 361 - 366 . DOI: 10.1016/s1368-8375(02)00120-3 http://doi.org/10.1016/s1368-8375(02)00120-3

LILLO S , MIRANDOLA A , VAI A , et al. Current status and future directions of proton therapy for head and neck carcinoma [J ] . Cancers (Basel) , 2024 , 16 ( 11 ): 2085 .

YU Y F , LU G Z , WANG R J , et al. Additional PD-1 inhibitor improves complete response to induction chemotherapy in locally advanced nasopharyngeal carcinoma [J ] . Front Immunol , 2024 , 15 : 1415246 .

LIU Q X , WANG J F , SUN C P , et al. The diagnosis and management of rare cystic liver metastases from nasopharyngeal carcinoma: a case report [J ] . Medicine (Baltimore) , 2018 , 97 ( 26 ): e11257.

JUAREZ-VIGNON WHALEY J J , AFKHAMI M , ONYSHCHENKO M , et al. Recurrent/metastatic nasopharyngeal carcinoma treatment from present to future: where are we and where are we heading? [J ] . Curr Treat Options Oncol , 2023 , 24 ( 9 ): 1138 - 1166 .

DAI J X , ZHANG B , SU Y X , et al. Induction chemotherapy followed by radiotherapy vs chemoradiotherapy in nasopharyngeal carcinoma: a randomized clinical trial [J ] . JAMA Oncol , 2024 , 10 ( 4 ): 456 - 463 .

DI CARLO S , CAVALLARO G , ROVERE F L , et al. Synchronous liver and peritoneal metastases from colorectal cancer: is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combined with liver resection a feasible option? [J ] . Front Surg , 2022 , 9 : 1006591 .

POON R T , FAN S T , LO C M , et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1 222 consecutive patients from a prospective database [J ] . Ann Surg , 2004 , 240 ( 4 ): 698-708;discussion 708 - 710 .

CHAMBERLAIN R S , CANES D , BROWN K T , et al. Hepatic neuroendocrine metastases: does intervention alter outcomes? [J ] . J Am Coll Surg , 2000 , 190 ( 4 ): 432 - 445 .

FONG Y , COHEN A M , FORTNER J G , et al. Liver resection for colorectal metastases [J ] . J Clin Oncol , 1997 , 15 ( 3 ): 938 - 946 . DOI: 10.1200/JCO.1997.15.3.938 http://doi.org/10.1200/JCO.1997.15.3.938

DELIS S , BILIATIS I , BOURLI A , et al. Surgical resection of a solitary liver metastasis from nasopharyngeal carcinoma: a case report [J ] . Hepatobiliary Pancreat Dis Int , 2006 , 5 ( 4 ): 610 - 612 .

CHEN L , WU L X , ZHANG L J , et al. Effect of metformin on hepatocellular carcinoma patients with type Ⅱ diabetes receiving transarterial chemoembolization: a multicenter retrospective cohort study [J ] . Int J Surg , 2025 , 111 ( 1 ): 828 - 838 .

TAN E H , KHOO K S , WEE J , et al. Phase Ⅱ trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma [J ] . Ann Oncol , 1999 , 10 ( 2 ): 235 - 237 .

FOO K F , TAN E H , LEONG S S , et al. Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type [J ] . Ann Oncol , 2002 , 13 ( 1 ): 150 - 156 . DOI: 10.1093/annonc/mdf002 http://doi.org/10.1093/annonc/mdf002

FANDI A , BACHOUCHI M , AZLI N , et al. Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type [J ] . J Clin Oncol , 2000 , 18 ( 6 ): 1324 - 1330 . DOI: 10.1200/JCO.2000.18.6.1324 http://doi.org/10.1200/JCO.2000.18.6.1324

TREHUB Y , MALOVANNA A , ZEMSKOV S . The current state of perioperative chemotherapy in resectable colorectal liver metastases: a narrative review [J ] . J Surg Oncol , 2025 .

Views

430

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

The efficacy and safety analysis of transarterial embolization in the treatment of cystic neuroendocrine neoplasm liver metastasis

The diagnostic value of zero echo time magnetic resonance imaging for skull base bone invasion in nasopharyngeal carcinoma

Evaluation of the efficacy and safety of TACE combined with anlotinib and sintilimab in the treatment of patient with CNLC stage ⅡB-ⅢB liver cancer

Study on the mechanism of DDX6 promoting proliferation and migration of nasopharyngeal carcinoma cells by regulating stability of CKMT1A mRNA

Efficacy, metabolic characteristics, safety and immunogenicity of AK-HER2 compared with reference trastuzumab in patients with metastatic HER2-positive breast cancer: a multicenter, randomized, double-blind phase Ⅲ equivalence trial

Related Author

Hang YU

Wensheng LIU

Ning ZHANG

Haikuan LIU

Luohai CHEN

Wang YAO

Wenzhe FAN

Jiaping LI

Related Institution

Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Pancreatic Cancer Institute, Fudan University, Shanghai Pancreatic Cancer Institute

Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-sen University

Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University

Center for Neuroendocrine Tumors, Department of Head, Neck and Neuroendocrine Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University

Department of Radiation Oncology, Fujian Cancer Hospital, Clinical Oncology School of Fujian Medical University

AI问答

⁰